Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Successful use of dabrafenib a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib

Bibliographic Details
Main Authors: Camille Pinard, MD, Claire Mignard, MD, Agnès Samain, MD, Anne-Bénédicte Duval-Modeste, MD, Pascal Joly, MD, PhD
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:JAAD Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S235251261730139X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S235251261730139X

Similar Items

  • Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
    by: Peter A. Young, MPAS, BS, et al.
    Published: (2021-03-01)
  • Polycyclic rash with persistent eosinophilia
    by: Lauren E. Merz, MD, MSc, et al.
    Published: (2021-06-01)
  • Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
    by: Davide Zanon, et al.
    Published: (2020-06-01)
  • Sulfasalazine-induced DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms)
    by: Renata Telles Rudge de Aquino, et al.
  • Drug rash with eosinophilia and systemic symptoms related to brentuximab vedotin: A report of 2 cases
    by: Laura Ragmanauskaite, MD, et al.
    Published: (2020-10-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...